Dermatology · Farmington, MO
NPI
1902844459
Since 2006
Specialty
Dermatology
Code 207N00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1223 Maple St
Farmington, MO, 63640
Phone (573) 760-0091
Groups this clinician bills Medicare through
Medicare paid, 2024
$203K
24,250 services
Medicare patients, 2024
1,278
Average age 75
Drug cost, 2024
$1.6M
1,683 prescriptions
Company payments, 2025
$996
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Samantha R McNail was code J7345 (aminolevulinic acid hcl for topical administration, 10% gel, 10 mg), 20,200 times for 84 patients. In total Samantha R McNail billed 24,250 services in 59 codes, and Medicare paid $203K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-08-23.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| J7345 Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg | Office | 20,200 | 84 | $1.31 | $26K |
| 17003 Destruction Skin Lesion | Office | 910 | 204 | $4.31 | $3,919 |
| 99213 Office E&M - Established | Office | 713 | 595 | $55.76 | $40K |
| 99212 Office E&M - Established | Office | 475 | 414 | $33.40 | $16K |
| 17000 Destruction Skin Lesion | Office | 385 | 300 | $35.94 | $14K |
| 17110 Destruction Skin Lesion | Office | 382 | 336 | $67.58 | $26K |
| 11102 Skin Biopsy | Office | 340 | 306 | $55.56 | $19K |
| 99203 Office E&M - New | Office | 102 | 102 | $63.00 | $6,426 |
| 11103 Skin Biopsy | Office | 96 | 71 | $32.42 | $3,112 |
| 99202 Office E&M - New | Office | 89 | 89 | $39.85 | $3,547 |
| 99214 Office E&M - Established | Office | 81 | 77 | $82.75 | $6,703 |
| 96573 Skin | Office | 72 | 63 | $128.83 | $9,276 |
| 17260 Destruction Skin Lesion | Office | 37 | 35 | $59.09 | $2,186 |
| 69100 Other Organ Systems | Office | 31 | 29 | $45.63 | $1,414 |
| 96567 Skin | Office | 27 | 26 | $95.55 | $2,580 |
By year: 2022 $175K for 9,139 services; 2023 $167K for 14,462 services; 2024 $203K for 24,250 services.
Medicare prescription drug claims, 2024
In 2024, the drug Samantha R McNail prescribed most often to Medicare patients was Ketoconazole, with 240 prescriptions and refills. In total Samantha R McNail wrote 1,683 Medicare prescriptions that cost $1.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ketoconazole Generic | 240 | 265 | 81 | $4,035 |
| Triamcinolone Acetonide Generic | 219 | 255 | 149 | $3,279 |
| Doxycycline Hyclate Generic | 174 | 216 | 37 | $3,398 |
| Fluorouracil Generic | 120 | 120 | 76 | $8,654 |
| Mupirocin Generic | 85 | 94 | 49 | $732 |
| Clobetasol Propionate Generic | 80 | 91 | 45 | $5,413 |
| Hydrocortisone Generic | 77 | 94 | 43 | $1,018 |
| Cephalexin Generic | 68 | 68 | 56 | $624 |
| Fluocinonide Generic | 56 | 68 | 27 | $1,973 |
| Fluconazole Generic | 56 | 56 | 17 | $685 |
| Prednisone Generic | 39 | 41 | 23 | $185 |
| Valacyclovir Valacyclovir Hcl | 38 | 38 | 16 | $203 |
| Minocycline Hcl Generic | 33 | 71 | 11 | $558 |
| Terbinafine Hcl Generic | 31 | 33 | 17 | $328 |
| Cosentyx Sensoready (2 Pens) Secukinumab | 26 | 26 | Under 11 | $220K |
Brand drugs: 214 claims; generic drugs: 1,469 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Samantha R McNail $996 ($996 in general payments such as food, travel and fees) from 14 companies. The largest payer was UCB, Inc. with $271.
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. UCB.BR | 9 | $271 |
| Janssen Biotech, Inc. JNJ | 16 | $261 |
| Lilly USA, LLC LLY | 3 | $75.86 |
| Novartis Pharmaceuticals Corporation NVS | 2 | $68.49 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 2 | $52.61 |
| Almirall LLC | 3 | $49.28 |
| Biofrontera Inc. | 2 | $43.67 |
| Galderma Laboratories, L.P. GALD.SW | 2 | $39.56 |
| Arcutis Biotherapeutics, Inc. ARQT | 2 | $36.93 |
| Regeneron Healthcare Solutions, Inc. REGN | 1 | $24.47 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.